Retiring from Walmart could trigger an abrupt and expensive shift at the pharmacy counter, with some former employees potentially absorbing up to $2,400 in annual drug costs under Medicare Part D in 2027.
Walmart (NASDAQ: WMT) announced on October 13 that its 2027 health plans would make more than 250 prescription medications available at no charge to qualifying employees and their dependents.
The zero-dollar coverage includes certain GLP-1 drugs, insulin products, and inhalers, all of which treat conditions disproportionately common among older workers approaching retirement age.
Enrollment in Walmart’s medical plans closes November 6, and nothing in the company’s announcement extends the benefit to former employees once they transition to Medicare.
A hypothetical 66-year-old associate managing both type 2 diabetes and asthma could pay nothing for all relevant prescriptions next year while still on Walmart’s payroll.
That same worker, upon retiring and enrolling in Medicare Part D, could face the program’s full $2,400 out-of-pocket ceiling in 2027, plus monthly plan premiums, depending on which drugs her Medicare plan covers.
The gap is illustrated starkly by a single inhaler priced at an illustrative $400 per month, which would cost nothing under Walmart’s benefit but could generate $1,725 in annual out-of-pocket spending under a 2027 Part D plan carrying a $700 deductible and standard 25% coinsurance.
Medicare does provide some protection on insulin, capping each covered product at $35 for a one-month supply regardless of deductible, which translates to a maximum of $420 per year per product, though that still compares unfavorably to Walmart’s $0 tier.
Workers who delay enrollment in Part D after losing employer coverage face an additional risk, since going 63 or more consecutive days without creditable prescription coverage can trigger a permanent late enrollment penalty of 1% of the national base beneficiary premium for each uncovered month.
Five variables will ultimately determine what a retiree pays: the drug’s placement on a plan’s formulary, whether a deductible applies, the coinsurance rate, which pharmacy network she uses, and whether the medication is covered at all.
Higher-income retirees face an additional layer of cost through IRMAA, a Part D surcharge ranging from $14.50 to $91 per month in 2026 that applies above $109,000 in income for single filers or $218,000 for joint filers, though the Centers for Medicare and Medicaid Services estimates only about 8% of Part D enrollees pay it.
At the opposite end of the income spectrum, the Extra Help program can significantly reduce premiums, deductibles, and coinsurance for enrollees with limited resources, and eligible retirees are encouraged to apply through Social Security before selecting a plan.
Medicare’s annual open enrollment period closes December 7, with any coverage changes taking effect January 1, though employees who retire later in 2027 may qualify for a separate special enrollment window when their employer coverage ends.
Financial planners generally advise workers to run their specific drug list through Medicare Plan Finder, matching exact drug names, dosages, and preferred pharmacies, well before leaving employer coverage to avoid an unwelcome surprise at the pharmacy.
